72 related articles for article (PubMed ID: 25369043)
1. [Quality of life of young adults after a growth hormone therapy with childhood onset].
Quitmann JH; Rohenkohl AC; Kammerer U; Schöfl C; Bullinger M; Dörr HG
Dtsch Med Wochenschr; 2014 Nov; 139(46):2335-8. PubMed ID: 25369043
[TBL] [Abstract][Full Text] [Related]
2. Quality of life and retrospective perception of the effect of growth hormone treatment in adult patients with childhood growth hormone deficiency.
Lagrou K; Xhrouet-Heinrichs D; Massa G; Vandeweghe M; Bourguignon JP; De Schepper J; de Zegher F; Ernould C; Heinrichs C; Malvaux P; Craen M
J Pediatr Endocrinol Metab; 2001; 14 Suppl 5():1249-60; discussion 1261-2. PubMed ID: 11964020
[TBL] [Abstract][Full Text] [Related]
3. Growth hormone regimens in Australia: analysis of the first 3 years of treatment for idiopathic growth hormone deficiency and idiopathic short stature.
Hughes IP; Harris M; Choong CS; Ambler G; Cutfield W; Hofman P; Cowell CT; Werther G; Cotterill A; Davies PS;
Clin Endocrinol (Oxf); 2012 Jul; 77(1):62-71. PubMed ID: 21950731
[TBL] [Abstract][Full Text] [Related]
4. Long-term mortality after recombinant growth hormone treatment for isolated growth hormone deficiency or childhood short stature: preliminary report of the French SAGhE study.
Carel JC; Ecosse E; Landier F; Meguellati-Hakkas D; Kaguelidou F; Rey G; Coste J
J Clin Endocrinol Metab; 2012 Feb; 97(2):416-25. PubMed ID: 22238382
[TBL] [Abstract][Full Text] [Related]
5. Growth hormone (GH) secretion and response to GH therapy after total body irradiation and haematopoietic stem cell transplantation during childhood.
Bakker B; Oostdijk W; Geskus RB; Stokvis-Brantsma WH; Vossen JM; Wit JM
Clin Endocrinol (Oxf); 2007 Oct; 67(4):589-97. PubMed ID: 17590170
[TBL] [Abstract][Full Text] [Related]
6. Evidence for social phobia and other psychiatric disorders in adults who were growth hormone deficient during childhood.
Stabler B; Tancer ME; Ranc J; Underwood LE
Anxiety; 1996; 2(2):86-9. PubMed ID: 9160606
[TBL] [Abstract][Full Text] [Related]
7. Long-term effects of growth hormone (GH) on bone mineral status and bone turnover markers in patients with isolated GH deficiency and multiple pituitary hormone deficiency.
Gonc EN; Kandemir N
Clin Endocrinol (Oxf); 2007 May; 66(5):672-7. PubMed ID: 17381489
[TBL] [Abstract][Full Text] [Related]
8. [Evaluation of final height in patients with pituitary growth hormone deficiency who were treated with growth hormone replacement].
Korpal-Szczyrska M; Dorant B; Kamińska H; Birkholz D; Niedźwiecki M
Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw; 2006; 12(1):31-4. PubMed ID: 16704859
[TBL] [Abstract][Full Text] [Related]
9. Cardiac dimension and function in patients with childhood onset growth hormone deficiency, before and after growth hormone retreatment in adult age.
Feinberg MS; Scheinowitz M; Laron Z
Am Heart J; 2003 Mar; 145(3):549-53. PubMed ID: 12660681
[TBL] [Abstract][Full Text] [Related]
10. Is the growth outcome of children with idiopathic short stature and isolated growth hormone deficiency following treatment with growth hormone and a luteinizing hormone-releasing hormone agonist superior to that obtained by GH alone?
Colmenares A; González L; Gunczler P; Lanes R
J Pediatr Endocrinol Metab; 2012; 25(7-8):651-7. PubMed ID: 23155689
[TBL] [Abstract][Full Text] [Related]
11. Health-Related Quality of Life of Young Adults Treated with Recombinant Human Growth Hormone during Childhood.
Sommer G; Gianinazzi ME; Kuonen R; Bohlius J; l'Allemand D; Hauschild M; Mullis PE; Kuehni CE;
PLoS One; 2015; 10(10):e0140944. PubMed ID: 26474398
[TBL] [Abstract][Full Text] [Related]
12. Growth in pre-pubertal children with myelomeningocele (MMC) on growth hormone (GH): the KIGS experience.
Trollmann R; Bakker B; Lundberg M; Doerr HG
Pediatr Rehabil; 2006; 9(2):144-8. PubMed ID: 16449073
[TBL] [Abstract][Full Text] [Related]
13. Acromegalic features in growth hormone (GH)-deficient patients after long-term GH therapy.
Carvalho LR; de Faria ME; Osorio MG; Estefan V; Jorge AA; Arnhold IJ; Mendonca BB
Clin Endocrinol (Oxf); 2003 Dec; 59(6):788-92. PubMed ID: 14974923
[TBL] [Abstract][Full Text] [Related]
14. Safety and efficacy of growth hormone (GH) during extended treatment of adult Japanese patients with GH deficiency (GHD).
Chihara K; Kato Y; Kohno H; Takano K; Tanaka T; Teramoto A; Shimatsu A
Growth Horm IGF Res; 2008 Aug; 18(4):307-17. PubMed ID: 18282776
[TBL] [Abstract][Full Text] [Related]
15. Bone age progression during the first year of growth hormone therapy in pre-pubertal children with idiopathic growth hormone deficiency, Turner syndrome or idiopathic short stature, and in short children born small for gestational age: analysis of data from KIGS (Pfizer International Growth Database).
Darendeliler F; Ranke MB; Bakker B; Lindberg A; Cowell CT; Albertsson-Wikland K; Reiter EO; Price DA
Horm Res; 2005; 63(1):40-7. PubMed ID: 15627781
[TBL] [Abstract][Full Text] [Related]
16. Age at growth hormone therapy start and first-year responsiveness to growth hormone are major determinants of height outcome in idiopathic short stature.
Ranke MB; Lindberg A; Price DA; Darendeliler F; Albertsson-Wikland K; Wilton P; Reiter EO;
Horm Res; 2007; 68(2):53-62. PubMed ID: 17228181
[TBL] [Abstract][Full Text] [Related]
17. Prader-Labhart-Willi syndrome: auxological response to a conventional dose of growth hormone in patients with classical growth hormone deficiency.
Schmidt H; Bechtold S; Schwarz HP
Eur J Med Res; 2000 Jul; 5(7):307-10. PubMed ID: 10903191
[TBL] [Abstract][Full Text] [Related]
18. Psychometric properties of two measures of psychological well-being in adult growth hormone deficiency.
McMillan CV; Bradley C; Gibney J; Russell-Jones DL; Sönksen PH
Health Qual Life Outcomes; 2006 Mar; 4():16. PubMed ID: 16553952
[TBL] [Abstract][Full Text] [Related]
19. Growth hormone secretion in adult patients with thalassaemia.
La Rosa C; De Sanctis V; Mangiagli A; Mancuso M; Guardabasso V; Galati MC; Caruso-Nicoletti M
Clin Endocrinol (Oxf); 2005 Jun; 62(6):667-71. PubMed ID: 15943827
[TBL] [Abstract][Full Text] [Related]
20. A polymorphism in the leptin receptor gene at position 223 is associated with growth hormone replacement therapy responsiveness in idiopathic short stature and growth hormone deficiency patients.
Su PH; Yang SF; Yu JS; Chen SJ; Chen JY
Eur J Med Genet; 2012 Dec; 55(12):682-7. PubMed ID: 23009903
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
